Evidence map›Paper›PMID 26399852›Full record

ArticleRetrovirology2015

Variants in the CYP7B1 gene region do not affect natural resistance to HIV-1 infection.

Manuela Sironi, Mara Biasin, Chiara Pontremoli, Rachele Cagliani, Irma Saulle, Daria Trabattoni, Francesca Vichi, Sergio Lo Caputo, Francesco Mazzotta, Wbeimar Aguilar-Jimenez and 5 more

Open access · goldAbstract read
In one paragraph

Article in Retrovirology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 96% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 8 institutions in 4 countries.

Manuela SironiScientific Institute IRCCS E. MEDEA, Bioinformatics, 23842, Bosisio Parini, Italy. msironi@bp.lnf.it.
Mara BiasinDepartment of Biomedical and Clinical Sciences "L. Sacco", University of Milan, Via G.B. Grassi 74, 20157, Milan, Italy. mara.biasin@unimi.it.
Chiara PontremoliScientific Institute IRCCS E. MEDEA, Bioinformatics, 23842, Bosisio Parini, Italy. chiara.pontremoli@bp.lnf.it.
Rachele CaglianiScientific Institute IRCCS E. MEDEA, Bioinformatics, 23842, Bosisio Parini, Italy. rachele.cagliani@bp.lnf.it.
Irma SaulleDepartment of Biomedical and Clinical Sciences "L. Sacco", University of Milan, Via G.B. Grassi 74, 20157, Milan, Italy. irma.saulle@unimi.it.
Daria TrabattoniDepartment of Biomedical and Clinical Sciences "L. Sacco", University of Milan, Via G.B. Grassi 74, 20157, Milan, Italy. daria.trabattoni@unimi.it.
Francesca VichiS. Maria Annunziata Hospital, 50122, Florence, Italy. francesca.vichi@asf.toscana.it.
Sergio Lo CaputoS. Maria Annunziata Hospital, 50122, Florence, Italy. sergio.locaputo@asf.toscana.it.
Francesco MazzottaS. Maria Annunziata Hospital, 50122, Florence, Italy. francesco.mazzotta@asf.toscana.it.
Wbeimar Aguilar-JimenezImmunovirology Group, School of Medicine, University of Antioquia UdeA, Medellín, Colombia. aguilar.wb@gmail.com.
Maria Teresa RugelesImmunovirology Group, School of Medicine, University of Antioquia UdeA, Medellín, Colombia. maria.rugeles@udea.edu.co.
Samandhy CedenoAIDS Research Institute-IrsiCaixa-HIVACAT, Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain. SCedeno@irsicaixa.es.
Jorge SanchezAsociación Civil Impacta Salud y Educación, Lima, Peru. jsanchez@impactaperu.org.
Christian BranderAIDS Research Institute-IrsiCaixa-HIVACAT, Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain. cbrander@irsicaixa.es.
Mario ClericiDepartment of Physiopathology and Transplantation, University of Milan, 20090, Milan, Italy. mario.clerici@unimi.it.
IRCCS Eugenio Medea · ITUniversity of Milan · ITAzienda Usl Toscana Centro · ITUniversidad de Antioquia · COUniversitat de Vic - Universitat Central de Catalunya · ESAsociación Civil Impacta Salud y Educación · PELuigi Sacco Hospital · ITOspedale Santa Maria Annunziata · IT

Funding

Consequences of acute HIV infection on the EBV-specific immunityR01DE018925 · NIDCR · MASSACHUSETTS GENERAL HOSPITAL · PI BRANDER, CHRISTIAN · 2007 to 2011
$1.3M
NIDCR NIH HHS R01 DE018925NIDCR NIH HHS R01 DE018925-04
6 · The paper itself

Abstract

backgroundThe genetic bases of natural resistance to HIV-1 infection remain largely unknown. Recently, two genome-wide association studies suggested a role for variants within or in the vicinity of the CYP7B1 gene in modulating HIV susceptibility. CYP7B1 is an appealing candidate for this due to its contribution to antiviral immune responses. We analyzed the frequency of two previously described CYP7B1 variants (rs6996198 and rs10808739) in three independent cohorts of HIV-1 infected subjects and HIV-1 exposed seronegative individuals (HESN).

findingsrs6996198 and rs10808739 were genotyped in three case/control cohorts of sexually-exposed HESN and HIV-1-infected individuals from Italy, Peru and Colombia. Comparison of the allele and genotype frequencies of the two SNPs under different models showed that the only significant difference was seen for rs6996198 in the Peruvian sample (nominal p = 0.048, dominant model). For this variant, a random-effect meta-analysis yielded non-significant results (dominant model, p = 0.78) and revealed substantial heterogeneity among cohorts. No significant effect of the rs10808739 allelic status on HIV-1 infection susceptibility (additive model, p = 0.30) emerged from the meta-analysis.

conclusionsAlthough our study had limited power to detect association due to the small sample size, comparisons among the three cohorts revealed very similar allelic and genotypic frequencies in HESN and HIV-1 positive subjects. Overall, these data indicate that the two GWAS-defined variants in the CYP7B1 region do not strongly influence HIV-1 infection susceptibility.

Indexed as

Genetic Predisposition to DiseaseAdultAllelesCytochrome P450 Family 7FemaleGenome-Wide Association StudyGenotypeHIV-1HIV InfectionsHumansImmunity, InnateMalePolymorphism, Single NucleotideSteroid HydroxylasesCYP7B1 protein, humanCytochrome P450 Family 7Steroid Hydroxylases

Identifiers

PMID26399852
PMCPMC4581478
OpenAlexW1937762621

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.